FDA Warning Letter — North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
The FDA took a Warning Letter action against North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding on November 18, 2022 (Richardson, TX). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
- Date
- November 18, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Center
- CDER
- Location
- Richardson, TX (United States)